CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J.
Right arrow Articles by Bishop, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J.
Right arrow Articles by Bishop, M. J.
Canadian Journal of Anesthesia 48:54-58 (2001)
© Canadian Anesthesiologists' Society, 2001

Regional Anesthesia and Pain

Epidural naloxone reduces intestinal hypomotility but not analgesia of epidural morphine

Jaemin Lee, MD, Jae Y. Shim, MD, Jeong H. Choi, MD, Eun S. Kim, MD, Ou K. Kwon, MD, Dong E. Moon, MD, Jong H. Choi, MD and Michael J. Bishop, MD*

* From the Department of Anesthesiology, Kangnam Saint Mary's Hospital, 505 Banpo-dong, Seocho-gu, Seoul, Korea. 137-040, and Puget Sound Veterans Affairs Medical Center
and the University of Washington School of Medicine, Seattle, Washington.

Address correspondence to: Dr. Jong H. Choi; Phone: 82-2-590-1545; Fax: 82-2-537-1951; E-mail: jchoi{at}cmc.cuk.ac.kr

Purpose: Epidural morphine is associated with decreased bowel motility and increased transit time. Low doses of intravenous naloxone reduce morphine-induced pruritus without reversing analgesia, but the effect of epidural naloxone on bowel motility has not been studied. Therefore we evaluated bowel motility and analgesia when naloxone was co-administered with morphine into the epidural space.

Methods: Forty-three patients having combined thoracic epidural and general anesthesia for subtotal gastrectomy were randomly assigned to one of two study groups. All received a bolus dose of 3 mg epidural morphine at the beginning of surgery, followed by a continuous epidural infusion containing 3 mg morphine in 100 ml bupivacaine 0.125% with either no naloxone (control group, n=18) or a calculated dose of 0.208 µg•kg–1•hr–1 of naloxone (experimental group, n=25) for 48 hr. We measured the time to the first postoperative passage of flatus and feces to evaluate the restoration of bowel function, and visual analog scales (VAS) for pain during rest and movement. Scores were assessed at 2, 4, 8, 16, 24, 36 and 48 hr postoperatively.

Results: The experimental group had a shorter time to the first postoperative passage of flatus (51.9 ± 16.6 hr vs 87.0 ± 19.5 hr, P < 0.001) and feces (95.3 ± 25.0 hr vs 132.9 ± 29.4 hr, P < 0.001). No differences were found in either resting or active VAS between the two groups.

Conclusion: Epidural naloxone reduces epidural morphine-induced intestinal hypomotility without reversing its analgesic effects.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
M. K. Kim, S. B. Nam, M. J. Cho, and Y.-S. Shin
Epidural naloxone reduces postoperative nausea and vomiting in patients receiving epidural sufentanil for postoperative analgesia
Br. J. Anaesth., August 1, 2007; 99(2): 270 - 275.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Canadian Anesthesiologists' Society.